MULTIVARIATE | Cancer specific survival | ||
---|---|---|---|
ANALYSES | HR | 95% CI | p-value |
Lymph Node Involvement present | |||
VI present, SDM present | 0.55 | 0.23 – 1.30 | 0.173 |
VI present, SDM absent | 2.78 | 0.80 – 9.64 | 0.108 |
VI absent, SDM present | 1.77 | 0.74 – 4.21 | 0.197 |
VI absent, SDM absent | 8.96 | 3.27 – 24.56 | <0.001 |
Venous invasion present | |||
LNI present | 0.63 | 0.25 – 1.64 | 0.349 |
LNI absent | 2.05 | 1.22 – 3.43 | 0.006 |
Synchronous distant metastases present | |||
LNI present | 0.93 | 0.32 – 2.74 | 0.894 |
LNI absent | 4.71 | 2.68 – 8.27 | <0.001 |
CCTS (Tumour size per 10 cm) | 1.49 | 0.75 – 2.95 | 0.256 |
ESR (≥ 28 mm vs. <28 mm ref.) | 1.94 | 1.15 – 3.26 | 0.012 |
ECOG PS (≥ 1 vs. 0) | 1.47 | 0.93 – 2.33 | 0.099 |
Mode of detection (Symptomatic vs. Incidental) | 0.66 | 0.25 – 1.71 | 0.392 |